Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.

British journal of haematology - 1 May 2008

Ricart José M, Ramón Luis A, Vayá Amparo, España Francisco, Santaolaria Maria-Luisa, Todolí José, Castelló Remedios, Fontcuberta Jordi, Estellés Amparo

Abstract excerpt

This study aimed to assess the fibrinolytic inhibitors and their association with thrombosis in Behçet disease. Thrombin activatable fibrinolysis inhibitor (TAFI) (P < 0.001) and plasminogen activator inhibitor-1 (PAI-1) levels (P = 0.022) were significantly higher in 79 patients than in 84 controls. No significant differences were observed in CPB2 (TAFI) Thr325Ile and SERPINE1 (PAI1) 4G/5G polymorphism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Behcet Syndrome
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carboxypeptidase B2

Share to Fibrinolysis

Share to Lipids

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Thrombosis

Source

Identifiers

PMID: 18341631
DOI: 10.1111/j.1365-2141.2008.07078.x

Genes

CPB2
SERPINE1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.PMID 18341631Read ↗

Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.Semantic proximity Read ↗

Association between thrombin-activatable fibrinolysis inhibitor gene polymorphisms and venous thrombosis risk: a meta-analysis.Semantic proximity Read ↗

A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.Semantic proximity Read ↗

Microparticles and their role in thrombosis in Behçet's Syndrome and their potential as a biomarker for thrombotic riskSemantic proximity Read ↗

Polymorphisms in the TAFI gene and the risk of venous thrombosis.Semantic proximity Read ↗

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review.Semantic proximity Read ↗

The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.Semantic proximity Read ↗

Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.Semantic proximity Read ↗

Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.Semantic proximity Read ↗

[Analytical choices for biological tests in thrombotic pathology].Semantic proximity Read ↗

The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease.Semantic proximity Read ↗

Genetic susceptibility to thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.